Sirio Pharma Co Ltd
SZSE:300791
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (18.2), the stock would be worth ¥22.82 (17% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 15.7 | ¥19.58 |
0%
|
| 3-Year Average | 18.2 | ¥22.82 |
+17%
|
| 5-Year Average | 18.9 | ¥23.7 |
+21%
|
| Industry Average | 22.2 | ¥27.83 |
+42%
|
| Country Average | 28.9 | ¥36.16 |
+85%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
¥7.8B
|
/ |
Oct 2025
¥453.1m
|
= |
|
|
¥7.8B
|
/ |
Dec 2025
¥258.6m
|
= |
|
|
¥7.8B
|
/ |
Dec 2026
¥466.1m
|
= |
|
|
¥7.8B
|
/ |
Dec 2027
¥544.9m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
Sirio Pharma Co Ltd
SZSE:300791
|
6B CNY | 15.7 | 17.4 | |
| FR |
|
L'Oreal SA
PAR:OR
|
201.5B EUR | 22.3 | 32.6 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
93.4B GBP | 12.8 | 11.2 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.5T INR | 40.1 | 37.7 | |
| UK |
|
HALEON PLC
LSE:HLN
|
31.6B GBP | 15 | 18.7 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
28.1B USD | 22.8 | -156 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
15.8B EUR | 9.8 | 16.9 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 15 | 22.4 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR | 40.3 | 61.2 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | -6 360.4 | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
800.1B INR | 39.1 | 43.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 16.6 |
| Median | 28.9 |
| 70th Percentile | 52.9 |
| Max | 49 021 |
Other Multiples
Sirio Pharma Co Ltd
Glance View
Sirio Pharma Co. Ltd. manufactures dietary supplement products. The company is headquartered in Shantou, Guangdong and currently employs 2,456 full-time employees. The company went IPO on 2019-09-25. The firm's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The firm's own brand is WEWOW nutritional health food. The firm distributes its products both in the domestic market and to overseas markets.
